Time-dependent decay of detectable antibodies against SARS-CoV-2: A comparison of ELISA with two batches of a lateral-flow test

Pütz, 2005, Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy, J Gen Virol, 86, 2955, 10.1099/vir.0.81265-0 Wu, 2007, Duration of antibody responses after severe acute respiratory syndrome, Emerg Infect Dis, 13, 1562, 10.3201/eid1310.070576 Antia, 2018, Heterogeneity and longevity of antibody memory to viruses and vaccines, PLoS Biol, 16, 10.1371/journal.pbio.2006601 Pollán M, Pérez-Gómez B, Pastor-Barriuso R, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet North Am Ed. 2020 Röltgen, 2020, SARS-CoV-2 antibody responses correlate with resolution of RNAemia but are short-lived in patients with mild illness, medRxiv Ibarrondo, 2020, Rapid decay of anti–SARS-CoV-2 antibodies in persons with mild Covid-19, N Engl J Med, 383, 1085, 10.1056/NEJMc2025179 Seow, 2020, Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection, medRxiv Long, 2020, Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections, Nat Med, 26, 1200, 10.1038/s41591-020-0965-6 Gaebler, 2020, Evolution of antibody immunity to SARS-CoV-2, bioRxiv Chen, 2020, A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients, PLoS Pathog, 16, 10.1371/journal.ppat.1008796 Crawford, 2020, Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infection, J Infect Dis, 223, 197, 10.1093/infdis/jiaa618 Dulipsingh, 2020, SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma, Transfus Apheresis Sci, 59, 10.1016/j.transci.2020.102922 Kaufman, 2020, Insights from patterns of SARS-CoV-2 immunoglobulin G serology test results from a national clinical laboratory, United States, march-July 2020, Popul Health Manag, 24, S35, 10.1089/pop.2020.0256 Lei, 2020, Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections, Allergy, 76, 551, 10.1111/all.14622 Liu, 2020, Associations of medications used during hospitalization and immunological changes in patients with COVID-19 during 3-month follow-up, Int Immunopharmacol, 89 Maine, 2020, Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott architect, J Clin Virol, 133, 10.1016/j.jcv.2020.104663 Nag, 2020, A Prospective study on rapidly declining SARS-CoV-2 IgG antibodies within one to three months of testing IgG positive: can It lead to potential reinfections?, Cureus, 12, e11845 Self, 2020, Decline in SARS-CoV-2 antibodies after mild infection among frontline health care personnel in a multistate hospital network - 12 states, April-August 2020, MMWR Morb Mortal Wkly Rep, 69, 1762, 10.15585/mmwr.mm6947a2 Wang, 2020, Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients, Int Immunopharmacol, 90 Rodda, 2020, Functional SARS-CoV-2-specific immune memory persists after mild COVID-19, Cell, 184, 169, 10.1016/j.cell.2020.11.029 Gudbjartsson, 2020, Spread of SARS-CoV-2 in the icelandic population, N Engl J Med, 382, 2302, 10.1056/NEJMoa2006100 Wajnberg, 2020, Robust neutralizing antibodies to SARS-CoV-2 infection persist for months, Science, eabd7728 Dan, 2020, Immunological memory to SARS-CoV-2 assessed for greater than six months after infection, bioRxiv Silveira, 2020, Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil, Nat Med, 26, 1196, 10.1038/s41591-020-0992-3 Hallal, 2020, SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys, Lancet Glob Health, 8, e1390, 10.1016/S2214-109X(20)30387-9 Alvim, 2020, An affordable anti-SARS-COV-2 spike protein ELISA test for early detection of IgG seroconversion suited for large-scale surveillance studies in low-income countries, medRxiv Pellanda, 2020, Sensitivity and specificity of a rapid test for assessment of exposure to SARS-CoV-2 in a community-based setting in Brazil, medRxiv Whitman, 2020, Evaluation of SARS-CoV-2 serology assays reveals a range of test performance, Nat Biotechnol, 38, 1174, 10.1038/s41587-020-0659-0 Sethuraman, 2020, Interpreting diagnostic tests for SARS-CoV-2, JAMA, 323, 2249, 10.1001/jama.2020.8259 Cao, 2007, Disappearance of antibodies to SARS-associated coronavirus after recovery, N Engl J Med, 357, 1162, 10.1056/NEJMc070348 Chang, 2005, Longitudinal analysis of severe acute respiratory syndrome (SARS) coronavirus-specific antibody in SARS patients, Clin Diagn Lab Immunol, 12, 1455 Borremans, 2020, Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset, eLife, 9, e60122, 10.7554/eLife.60122 Isho, 2020, Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients, Sci Immunol, 5, eabe5511, 10.1126/sciimmunol.abe5511